Home Cart 0 Sign in  
X

[ CAS No. 1462-86-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 1462-86-8
Chemical Structure| 1462-86-8
Chemical Structure| 1462-86-8
Structure of 1462-86-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1462-86-8 ]

Related Doc. of [ 1462-86-8 ]

Alternatived Products of [ 1462-86-8 ]

Product Details of [ 1462-86-8 ]

CAS No. :1462-86-8 MDL No. :MFCD00090153
Formula : C6H6N2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :BOOMHTFCWOJWFO-UHFFFAOYSA-N
M.W : 138.12 Pubchem ID :73836
Synonyms :

Calculated chemistry of [ 1462-86-8 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 35.6
TPSA : 76.21 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.73 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.25
Log Po/w (XLOGP3) : 0.58
Log Po/w (WLOGP) : 0.37
Log Po/w (MLOGP) : -1.72
Log Po/w (SILICOS-IT) : 0.03
Consensus Log Po/w : -0.1

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -1.44
Solubility : 5.02 mg/ml ; 0.0363 mol/l
Class : Very soluble
Log S (Ali) : -1.75
Solubility : 2.44 mg/ml ; 0.0176 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.01
Solubility : 13.5 mg/ml ; 0.0977 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.25

Safety of [ 1462-86-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1462-86-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1462-86-8 ]
  • Downstream synthetic route of [ 1462-86-8 ]

[ 1462-86-8 ] Synthesis Path-Upstream   1~27

  • 1
  • [ 59290-85-6 ]
  • [ 1462-86-8 ]
YieldReaction ConditionsOperation in experiment
67%
Stage #1: With hydrogen; sodium hydrogencarbonate In water at 20℃; for 50 h;
Stage #2: With hydrogenchloride In water
(2) Manufacture of 3-aminopyridine-2-carboxylic acid 3-nitropyridine-2-carboxylic acid (2.72 g, 16.2 mmol) and sodium hydrogencarbonate (1.34 g, 16.2 mmol) were dissolved in distilled water (20 mL), and the atmosphere in the system was replaced by nitrogen. After adding 10percent palladium charcoal (1.72 g), the atmosphere in the system was replaced by hydrogen, and the mixture stirred at room temperature for 50 hours. 1N hydrochloric acid aqueous solution was added, and the pH of the reaction solution was adjusted to weak acidity. The solvent was distilled off under reduced pressure, a small amount of ethanol and ethyl acetate were added to the residue, and the precipitate produced was filtered off. The filtrate was concentrated, and the target substance (1.50 g, 67percent) was thus obtained as a light yellow solid.
Reference: [1] Patent: US2005/182045, 2005, A1, . Location in patent: Page/Page column 74
  • 2
  • [ 4664-00-0 ]
  • [ 1462-86-8 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2001, vol. 9, # 8, p. 2061 - 2071
[2] Journal of Medicinal Chemistry, 1989, vol. 32, # 9, p. 2116 - 2128
  • 3
  • [ 4663-94-9 ]
  • [ 1462-86-8 ]
Reference: [1] Journal of Medicinal Chemistry, 1996, vol. 39, # 15, p. 3019 - 3029
  • 4
  • [ 699-98-9 ]
  • [ 1462-86-8 ]
Reference: [1] Journal of Medicinal Chemistry, 1989, vol. 32, # 9, p. 2116 - 2128
  • 5
  • [ 89-00-9 ]
  • [ 1462-86-8 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2001, vol. 9, # 8, p. 2061 - 2071
  • 6
  • [ 1462-86-8 ]
  • [ 57266-69-0 ]
Reference: [1] Journal fuer Praktische Chemie (Leipzig), 1932, vol. <2> 133, p. 36,49
  • 7
  • [ 1462-86-8 ]
  • [ 73841-32-4 ]
Reference: [1] Journal fuer Praktische Chemie (Leipzig), 1937, vol. <2> 148, p. 13,16
  • 8
  • [ 1462-86-8 ]
  • [ 114080-95-4 ]
Reference: [1] Journal fuer Praktische Chemie (Leipzig), 1932, vol. <2> 133, p. 36,49
  • 9
  • [ 1462-86-8 ]
  • [ 874-24-8 ]
Reference: [1] Journal of Organic Chemistry, 2004, vol. 69, # 1, p. 54 - 61
  • 10
  • [ 1462-86-8 ]
  • [ 50608-99-6 ]
Reference: [1] Journal of the American Chemical Society, 1956, vol. 78, p. 973,974
[2] Journal of the Chemical Society, 1956, p. 1045,1053
  • 11
  • [ 1462-86-8 ]
  • [ 18107-18-1 ]
  • [ 14667-47-1 ]
Reference: [1] Patent: WO2009/90401, 2009, A2, . Location in patent: Page/Page column 45
  • 12
  • [ 64-17-5 ]
  • [ 1462-86-8 ]
  • [ 27507-15-9 ]
YieldReaction ConditionsOperation in experiment
65% at 20 - 100℃; for 72 h; A suspension of 3-aminopicolinic acid (1-18) (28 g, 200 mmoL, 1.0 eq) in EtOH (800 mL) at room temperature was bubbled with HCI (g) for 10 min. The reaction turned into a clear yellow solution. After being stirred at 100°C for 1 day, LCMS indicated that about 50percent of starting material remained. The reaction mixture was cooled to rt and bubbled with HCI (g) for 10 min. The mixture was then re-heated to 100 °C. After being stirred at 100 °C for 1 day, LCMS indicated that about 50percent of the starting material remained. The reaction mixture was cooled to rt and all solvents were removed under reduced pressure. The residue was resolved in EtOH (800 mL) and was bubbled with HCI (g) for 10 min. The resulting mixture was refluxed at 100°C oil bath for 1 day. LCMS indicated about 70-75 percent conversion. The reaction mixture was cooled to rt and all solvents were removed under reduced pressure. The solid was dissolved in 250 mL water and the solution was quenched to pH = 8-9 with saturated aq Na2C03. A gas was generated and a white solid formed. The suspension was filtered, washed with water, and dried under vacuum at 65°C to afford 22 g of ethyl 3-aminopicolinate (1-19) in 65percent yleld as a white solid. LCMS (APCI, M+ + 1 ) 167.0; 1H NMR (300 MHz, DMSO-c/6) 8 ppm 7.84 (dd, J = 4.05, 1 .60 Hz, 1 H), 7.23 - 7.30 (m, 1 H), 7.16 - 7.23 (m, 1 H), 6.65 (br. s., 2 H), 4.27 (q, J = 7.10 Hz, 2 H), 1 .30 (t, J = 7.06 Hz, 3 H).
Reference: [1] Journal of Organic Chemistry, 2004, vol. 69, # 1, p. 54 - 61
[2] Patent: WO2016/97918, 2016, A1, . Location in patent: Page/Page column 55
[3] Journal of Medicinal Chemistry, 2008, vol. 51, # 7, p. 2196 - 2207
[4] Journal of the Chemical Society, 1949, p. 3304,3310
[5] Journal of the Chemical Society, 1956, p. 1045,1053
[6] Journal of the Chemical Society, 1949, p. 3304,3310
[7] Journal of the Chemical Society, 1956, p. 1045,1053
[8] Bulletin de la Societe Chimique de France, 1992, # 1, p. 79 - 84
[9] Patent: WO2008/24438, 2008, A2, . Location in patent: Page/Page column 44
[10] Patent: WO2008/24433, 2008, A2, . Location in patent: Page/Page column 46
[11] Patent: WO2008/66664, 2008, A2, . Location in patent: Page/Page column 44
[12] Patent: WO2012/74951, 2012, A1, . Location in patent: Page/Page column 47
[13] Patent: WO2009/121036, 2009, A2, . Location in patent: Page/Page column 42
  • 13
  • [ 1462-86-8 ]
  • [ 37538-67-3 ]
Reference: [1] Journal of the Chemical Society, 1956, p. 1045,1053
[2] Journal of the American Chemical Society, 1956, vol. 78, p. 973,974
[3] Patent: US5034393, 1991, A,
  • 14
  • [ 1462-86-8 ]
  • [ 77287-34-4 ]
  • [ 37538-67-3 ]
Reference: [1] Journal of the Chemical Society, 1956, p. 1045,1053
[2] Journal of the American Chemical Society, 1946, vol. 68, p. 914
  • 15
  • [ 1462-86-8 ]
  • [ 39551-54-7 ]
Reference: [1] Journal of the Chemical Society, 1956, p. 1045,1053
[2] Journal of the American Chemical Society, 1956, vol. 78, p. 973,974
[3] Patent: US2012/122838, 2012, A1,
[4] Patent: WO2013/12915, 2013, A1,
[5] Patent: CN106083742, 2016, A,
[6] RSC Advances, 2017, vol. 7, # 36, p. 22360 - 22368
  • 16
  • [ 1462-86-8 ]
  • [ 57-13-6 ]
  • [ 37538-68-4 ]
YieldReaction ConditionsOperation in experiment
27% at 200℃; for 5 h; (1) 4 g of 3-aminopyridine-2-carboxylic acid (starting material A3), 20 g of urea was refluxed at 200 ° C for 5 h to give intermediate B3, The yield of 27percent; specific reaction equation is as follows:
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 9, p. 2663 - 2670
[2] Patent: CN106083742, 2016, A, . Location in patent: Paragraph 0185; 0186; 0187
[3] Journal of the Chemical Society, 1956, p. 1045,1053
  • 17
  • [ 1462-86-8 ]
  • [ 37538-68-4 ]
Reference: [1] Chemische Berichte, 1952, vol. 85, p. 1012,1019
[2] Journal of the American Chemical Society, 1956, vol. 78, p. 973,974
  • 18
  • [ 67-56-1 ]
  • [ 1462-86-8 ]
  • [ 36052-27-4 ]
YieldReaction ConditionsOperation in experiment
77% for 120 h; Reflux (Step 1) (1070) To a solution of 3-aminopyridine-2-carboxylic acid (20 g, 144.9 mmol) in methanol (300 mL) was added conc. sulfuric acid (5.4 mL), and the mixture was heated under reflux for 5 days. The reaction mixture was concentrated under reduced pressure, water was added thereto, and sodium carbonate was added thereto until the complete of foaming. The mixture was extracted with dichloromethane (x3), the organic layer was dried over sodium sulfate, and the solvent was evaporated under reduced pressure to give methyl 3-aminopyridine-2-carboxylate (17.0 g, 77percent) as a pale yellow solid. 1H-NMR(300MHz,CDCl3):δ3.95(3H,s),5.72(2H,brs),7.03(1H,dd,J=0.99,8. 35Hz),7.18-7.21(1H,m),8.05(1H,dd,J=0.96,4.04Hz).
76%
Stage #1: at 80℃; for 168 h;
Stage #2: With sodium carbonate In water
A solution of 3-aminopyridine-2-carboxylic acid(Bioorg. Med Chem. 2001,9, 2061) (1.0 g, 7.25 mmol) andH2SO4 (2.75 ml) in methanol (15 ml) was heated at 80 oC for 7 days. The reaction was cooled and the methanol removed by evaporation. The residue was poured into water (ca. 30 ml) and solid sodium carbonate was added until effervescence ceased(pH ~7). The mixture was extracted with dichloromethane (4 x 50 ml) and the combined organic fractions dried over MgS04 and concentrated to give the title compound as a beige solid (0. 84 g, 76 percent). 1H NMR (360 MHz,CDCl3) 8 8.07(1H, dd, J4. 2,1. 4), 7.22(1H, dd,J8. 4,4. 2), 7.05(1H, dd, J8. 4,1. 4), 5.73 (2H, brs), 3.98 (3H, s).Mlz (ES+) 153 (M+H+).
54.47% at 15 - 80℃; for 120 h; To a suspension of 3-aminopicolinic acid (100 g, 724 mmol, 1.0 eq.) in dry MeOH (1.5 L) was added conc.H2SO4 (460 g, 4.69 mol, 6.48 eq.) dropwise at 15° C. and the mixture was heated to 80° C. and stirred for 5 days.
The reaction mixture was concentrated to about 500 mL and diluted with cold water (2 L).
The resulting mixture was adjusted to about 9 with solid Na2CO3 at 0° C. and extracted with DCM/MeOH (10:1, 1.0 L*5).
The combined orange layers were dried over Na2SO4, filtered and concentrated to give methyl 3-aminopicolinate (60 g, 394.35 mmol, 54.47percent yield, 100percent purity) as a brown solid. 1H NMR (400 MHz, CDCl3) δ=8.08-8.06 (m, 1H), 7.24-7.20 (m, 1H), 7.06-7.01 (m, 1H), 5.75 (br. s, 1H), 3.97 (s, 3H). ESI [M+H]=153.1
41% With hydrogenchloride In water at 85℃; for 12 h; 3-Aminopyridine-2-carboxylic acid (10.0 g, 72.5 mmol) was dissolved in methanol (100 ml). After cooling to 0° C., concentrated hydrochloric acid (25 ml) was added dropwise thereto, and the reaction solution was stirred at 85° C. for 12 hours. After the solvent was removed under reduced pressure, water and sodium hydrogen carbonate (10 g) were added to the obtained residue, followed by stirring and extraction with ethyl acetate (80 ml×4). The extraction liquids were combined, washed with saturated aqueous sodium chloride, and dried over anhydrous sodium sulfate. Then, the solvent was removed under reduced pressure. The residue was stirred in petroleum ether/ ethyl acetate=8:1, and the obtained solid was filtered and dried under reduced pressure to obtain the title compound (4.50 g, 41percent). [1164] 1H-NMR (400 MHz, DMSO-d6): δ 7.85-7.83 (m, 1H), 7.27-7.20 (m, 2H), 6.66 (s, 2H), 3.80 (s, 3H).; MS (ESI) m/z 153 (M+H)+

Reference: [1] Patent: EP2975031, 2016, A1, . Location in patent: Paragraph 1070
[2] Patent: WO2005/49613, 2005, A1, . Location in patent: Page/Page column 39
[3] Patent: US2017/190713, 2017, A1, . Location in patent: Paragraph 0260
[4] Patent: US2015/51395, 2015, A1, . Location in patent: Paragraph 1163-1164
[5] Chemical Communications, 2016, vol. 52, # 59, p. 9283 - 9286
  • 19
  • [ 1462-86-8 ]
  • [ 18107-18-1 ]
  • [ 36052-27-4 ]
YieldReaction ConditionsOperation in experiment
54% at 20℃; Example 6; Synthesis of (+/-)-9- [acetyl -(3 ,5-bis-trifluoi"omethylbenzyl)amino] -2-bromo-6,7 ,8 ,9- tetrahydro-pyrido[3,2-b]azepine-5-carboxylic acid'isopropyl ester; Step 1;. Preparation of 3-amino-pyridine-2-carboxylic acid methyl ester; Add dropwise a solution of trimethylsilyl diazomethane (2.0 M in toluene, 7.24 mL, 14.48 mmol) to a solution of 3-amino-pyridine-2-carboxylic acid (1.0 g, 7.24 mmol) in ethyl acetate (5 mL) and methanol (5 mL) at room temperature. After the addition is complete, remove the solvent under reduced pressure. Suspend the residue in water (5 mL), add a saturated solution of sodium bicarbonate, and extract with ethyl acetate. Separate the organic layer, dry over sodium sulfate, and filter. Remove the solvent under reduced pressure to afford the title compound (590 mg, 54percent). MS (ES+): 153 (M+H).
Reference: [1] Patent: WO2005/97805, 2005, A1, . Location in patent: Page/Page column 53-54
[2] Patent: WO2009/9740, 2009, A1, . Location in patent: Page/Page column 58
  • 20
  • [ 186581-53-3 ]
  • [ 1462-86-8 ]
  • [ 36052-27-4 ]
Reference: [1] Patent: US5801183, 1998, A,
  • 21
  • [ 186581-53-3 ]
  • [ 1462-86-8 ]
  • [ 36052-27-4 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2001, vol. 9, # 8, p. 2061 - 2071
  • 22
  • [ 1462-86-8 ]
  • [ 51674-77-2 ]
Reference: [1] Patent: US2012/122838, 2012, A1,
[2] Patent: WO2013/12915, 2013, A1,
  • 23
  • [ 1462-86-8 ]
  • [ 25797-03-9 ]
Reference: [1] Chemical Communications, 2016, vol. 52, # 59, p. 9283 - 9286
  • 24
  • [ 24424-99-5 ]
  • [ 1462-86-8 ]
  • [ 569687-82-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2003, vol. 46, # 13, p. 2631 - 2640
  • 25
  • [ 1462-86-8 ]
  • [ 824429-51-8 ]
Reference: [1] Chemical Communications, 2016, vol. 52, # 59, p. 9283 - 9286
  • 26
  • [ 1462-86-8 ]
  • [ 866775-09-9 ]
Reference: [1] Patent: EP2975031, 2016, A1,
[2] Patent: US2017/190713, 2017, A1,
  • 27
  • [ 1462-86-8 ]
  • [ 1052708-46-9 ]
Reference: [1] Patent: EP2975031, 2016, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1462-86-8 ]

Amines

Chemical Structure| 36052-27-4

[ 36052-27-4 ]

Methyl 3-aminopicolinate

Similarity: 0.92

Chemical Structure| 27507-15-9

[ 27507-15-9 ]

Ethyl 3-aminopicolinate

Similarity: 0.89

Chemical Structure| 870997-85-6

[ 870997-85-6 ]

3-Amino-5-bromopyridine-2-carboxylic Acid

Similarity: 0.87

Chemical Structure| 52378-63-9

[ 52378-63-9 ]

(3-Aminopyridin-2-yl)methanol

Similarity: 0.84

Chemical Structure| 866807-27-4

[ 866807-27-4 ]

3-Amino-6-chloropyridine-2-carboxylic acid

Similarity: 0.83

Carboxylic Acids

Chemical Structure| 870997-85-6

[ 870997-85-6 ]

3-Amino-5-bromopyridine-2-carboxylic Acid

Similarity: 0.87

Chemical Structure| 934-60-1

[ 934-60-1 ]

6-Methyl-2-pyridinecarboxylic acid

Similarity: 0.84

Chemical Structure| 98-98-6

[ 98-98-6 ]

2-Pyridinecarboxylic acid

Similarity: 0.84

Chemical Structure| 866807-27-4

[ 866807-27-4 ]

3-Amino-6-chloropyridine-2-carboxylic acid

Similarity: 0.83

Chemical Structure| 1112213-20-3

[ 1112213-20-3 ]

3-Amino-6-chloropicolinic acid hydrochloride

Similarity: 0.83

Related Parent Nucleus of
[ 1462-86-8 ]

Pyridines

Chemical Structure| 36052-27-4

[ 36052-27-4 ]

Methyl 3-aminopicolinate

Similarity: 0.92

Chemical Structure| 27507-15-9

[ 27507-15-9 ]

Ethyl 3-aminopicolinate

Similarity: 0.89

Chemical Structure| 870997-85-6

[ 870997-85-6 ]

3-Amino-5-bromopyridine-2-carboxylic Acid

Similarity: 0.87

Chemical Structure| 934-60-1

[ 934-60-1 ]

6-Methyl-2-pyridinecarboxylic acid

Similarity: 0.84

Chemical Structure| 52378-63-9

[ 52378-63-9 ]

(3-Aminopyridin-2-yl)methanol

Similarity: 0.84